St. Elizabeth's Medical Center is the first hospital in New England to offer breakthrough CorPath® Angioplasty, the only robotic-assisted angioplasty system enables physicians to place a stent in the coronary arteries to treat heart conditions.
The CorPath® 200 System is a new state-of-the-art tool that our interventional cardiologists can use to perform angioplasty with robotic precision. The robotic-assisted system leverages a physician’s skills by providing a tool to precisely control stent and balloon catheters while treating a patient's heart.
The vascular robot includes the following state-of-the-art equipment:
Robotic drive: The robotic drive is the ‘engine’ of the system that translates a cardiologist’s commands into precise movements and manipulations of the coronary stents and catheters. The drive is mounted to an articulated arm that attaches to the procedure table.
The doctor controls the devices, such as stents and balloons, using the CorPath 200 System. Studies show that optimal precision in the placement of these interventional treatment devices results in better outcomes and a reduction in the number of repeat procedures necessary.
Interventional cockpit: The procedure is performed in the catheterization lab. Using an enhanced “interventional cockpit”, the cardiologist uses special controllers to precisely manipulate the balloons and stents. While operating from the cockpit, they have a close proximity view of the angiography screens and coronary arteries to aid in a patient's treatment.
St. Elizabeth’s Medical Center performed New England’s first robotic-assisted coronary angioplasty as part of the successful CorPath PRECISE trial sponsored by Corindus Vascular Robotics, which was overseen by Joseph P. Carrozza, Jr., MD, St. Elizabeth’s chief of cardiovascular medicine and co-principal investigator of the PRECISE trial.